Pedro Victor López Plaza
Barcelona, Spain
Location contact
Ismael Ordoñez
SUB_INVESTIGATOR
Julio Gómez Soriano
SUB_INVESTIGATOR
Lorenzo Escutia
SUB_INVESTIGATOR
Pedro V López
CONTACT
Pedro Victor López Plaza
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06936579
Through motor muscle potentials, we will observe how a peripheral somatosensory mechanical stimulus on key limb musculature communicates signals via afferent sensory fibers that encode proprioceptive signals from muscle spindles (particularly type Ia fibers) to the somatosensory cortex at rest, confirming the integrative hypothesis of movement.
These results would support interventions aimed at addressing sensory deafferentation present in multiple health conditions related to movement disorders, where disuse or immobilization lead to changes in movement patterns and a decrease in neuronal activation in somatosensory cortex areas involved in constructing voluntary movement.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
Barcelona, Spain
Ismael Ordoñez
SUB_INVESTIGATOR
Julio Gómez Soriano
SUB_INVESTIGATOR
Lorenzo Escutia
SUB_INVESTIGATOR
Pedro V López
CONTACT
Pedro Victor López Plaza
PRINCIPAL_INVESTIGATOR
Objective: To evaluate whether a proprioceptive stimulus applied to the limb of healthy subjects activates the corticospinal pathway, compared to a condition without stimulation, through the analysis of motor evoked potentials (MEPs).
Methods: Experimental and crossover. Each participant will serve as their own control and will be assessed under both stimulation (experimental) and no-stimulation (control) conditions.The stimulus will consist of intermittent mechanical pressure on the skin located at the neuromuscular motor points (NMPs) of the upper limb (biceps muscle (B) and wrist extensors (WE)) and the lower limb (rectus femoris of the quadriceps (RFQ) and tibialis anterior (TA).Motor evoked potentials (MEPs) will be recorded from the B, WE, RFQ, and TA muscles using transcranial magnetic stimulation (TMS).The optimal stimulation point (hotspot-the area where TMS generates the highest MEP) will be identified individually for the B, WE, RFQ, and TA muscles.Participants will be recruited at the facilities of the Faculty of Physiotherapy and Nursing of Castilla-La Mancha University (UCLM), in collaboration with the Toledo Physiotherapy Research Group (GIFTO) and the Faculty of Health Sciences, Blanquerna - Ramon Llull University.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Good health status with no history of neuromuscular injuries, surgical interventions, or trauma affecting the central or peripheral nervous system.
Not currently taking drugs or medications known to affect the central nervous system, and not pregnant at the time of testing.
No metallic or electronic implants and no history of epilepsy.
(Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research)
Condition without proprioceptive stimulation: Participants will not receive the stimulus, and MEP activity will be recorded under the same motor cortex stimulation conditions.
Condition with proprioceptive stimulation 1: Participants will receive proprioceptive stimulation through the output plunger, applied continuously for 15 seconds, with 20-second rest intervals, over a total duration of 5 minutes. MEP activity will then be recorded via motor cortex stimulation.
Condition with proprioceptive stimulation 2: Participants will receive proprioceptive stimulation continuously during the application of TMS pulses while MEP activity is recorded.
Time frame: 45 minuts
transcranial magnetic stimulation (TMS)
Contact information is provided by the study sponsor or research team.
Facultat de ciencies de la Salut Universitat Ramon Llull
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07395609
Healthy Subjects, Subjective Cognitive Decline (SCD)
Gainesville, Florida, United States
View Trial DetailsNCT07615699
Choroid Diseases, Choroidal Diseases
View Trial DetailsNCT07584304
Healthy Subjects
View Trial DetailsNCT07560033
Healthy Subjects
View Trial Details